glp-1 gip lilly First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test! Eli announced positive topline results from the Eli Lilly and phase results
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17


























